NIA Academic Leadership K07 Eligibility Guide

Full answer: NIA Academic Leadership K07 eligibility in 2026 starts with one hard rule: under PAR-24-321, the applicant must be a named PD/PI on an active NIA R01 or R01-equivalent (or a sub-project of a multi-component NIA award) at submission. After that, fit turns on 8 steps: aging mission fit, academic leadership role, candidate stage, career-development plan, institutional support, no-trial-lead status, mentor or advisory structure, and route choice.

Data note: This guide uses NIH PAR-24-321, the NIH K07 activity-code page, NIA research training and career development information, Grants.gov, the live NIA Academic Leadership K07 program record, and Grantsights award-data signals checked on May 26, 2026.

Source review by Grantsights, June 3, 2026: We rechecked NIH PAR-24-321, NIH K07 activity-code guidance, NIA training and career-development pages, NIH data-sharing rules, Grants.gov package status, and the live Grantsights program page. Where official sources stop: PAR-24-321 is an NIA academic-leadership career award for aging or AD/ADRD research capacity, and the candidate cannot lead an independent clinical trial.

Who this is for: This guide is for aging researchers, department leaders, sponsored-research offices, and research administrators checking NIA Academic Leadership K07 eligibility before writing the career plan, institutional letter, and route memo.

NIA Academic Leadership K07 Guide (2026)

According to NIH PAR-24-321, the NIA Academic Leadership Career Award K07 is the no-independent-clinical-trial route for applicants building academic leadership and research-career capacity in aging-related work. The live NIA Academic Leadership K07 program record should be checked for current dates and award rows.

The search-intent problem is not "Can I write a career plan?" It is "Can I prove that the candidate, institution, and aging-research leadership role need a K07 rather than K01, K08, K23, K24, R01, R03, or a training program?" Some K applications read as generic professional-development plans. That is a bad fit when reviewers expect a clear aging-research leadership path.

Use this guide with the NIH K01 career development award guide, NIH K99/R00 guide, NIH R01, R21, R03, and K awards comparison, NIH K24 Midcareer Investigator guide, NCMRR Early Career R03 guide, NIGMS MIRA R35 guide, and the Grantsights grant database.

Last updated: October 2026

8 NIA Academic Leadership K07 Eligibility Checks

Within 14 days, confirm the active-award rule in the first row, then run the 8-step checklist below it before writing the candidate statement.

According to NIH PAR-24-321, the route does not allow the candidate to lead an independent clinical trial, and the applicant must already hold an active NIA R01 or R01-equivalent as a named PD/PI. The NOFO also expects candidates to keep research support during the award. Those two rules don't end the route screen. The stronger question is whether the award would create academic leadership capacity in aging research that another mechanism would not.

5 Source Facts Applicants Should Know

Within 7 days, put these 5 source facts into a route memo. First, according to NIH PAR-24-321, this is an NIA Academic Leadership K07 route. Second, according to NIH K07 activity-code guidance, K07 is a leadership or academic career-award activity code, not a research project grant. Third, according to NIA training information, NIA career programs sit inside a broader aging-research workforce strategy. Fourth, according to Grants.gov, applicants still need the official package and date check. Fifth, according to Grantsights award data, the live program page should be checked for award rows.

The budget rules are specific. According to PAR-24-321, NIH will contribute up to $75,000 a year toward the candidate's salary and up to $50,000 a year for research development costs. Up to $25,000 a year may be requested for a curriculum development or research coordinator, and salary for the candidate plus the coordinator may not exceed $100,000 in total direct costs, inclusive of fringe. The project period may not exceed 5 years. The notice expires November 13, 2027, and NIH updated it on March 31, 2025 to align with agency priorities, so reread the current text before drafting.

What NIH Doesn't Tell You

The official notice can state eligibility, but it doesn't decide whether the leadership plan is credible. The practical gap is the gap between formal K07 rules and reviewer confidence. A K07 application can be technically eligible but still weak if it cannot explain what leadership capacity changes in the department, center, school, or aging-research program.

Grantsights analysis of award data and route evidence says applicants should apply when the candidate has a real aging-research leadership role, an institutional commitment, and a career plan that changes research capacity. If the plan is mostly course attendance, protected writing time, or a vague leadership promise, it may be a bad fit.

For example, a faculty member who already leads an active NIA R01 and would use the award to build an aging-methods core with named junior investigators, data resources, and a chair-backed role could fit. An investigator without an active NIA R01-equivalent isn't eligible at all, and one who mainly wants protected time to finish existing research should compare K24, R01, or K01 before K07. The difference is whether the award creates academic leadership capacity, not whether the applicant has a good CV.

5 Bad-Fit Signals

Within 14 days, stop on these 5 signals, plus one hard stop: no active NIA R01-equivalent with the candidate as a named PD/PI. First, aging research is not the center of the plan. Second, the candidate does not have a defined academic leadership role. Third, the institution cannot explain what it will protect or provide. Fourth, the candidate plans to lead an independent clinical trial. Fifth, a K01, K24, K12, R01, or R03 would explain the need better.

K-route mistakes often show up in the first paragraph. If the page or draft starts with "I need time" instead of "this award changes aging-research leadership capacity," the case is thin. Don't make reviewers infer the institutional value. Say it plainly.

5 Route Choices Before Drafting

Within 7 days, compare 5 routes.

Use the NIH R01, R21, R03, and K awards comparison if you're still deciding whether the issue is a candidate, a project, or an institution-level training plan.

5 Signals Readers Can Use

Within 14 days, use these 5 signals before drafting. Signal 1 is the aging mission. Signal 2 is the leadership role. Signal 3 is the career plan. Signal 4 is institutional support. Signal 5 is the route comparison.

The public notice gives the rule path. If the route might fit, draft the route memo; skip it if the leadership case is weak or the candidate has no active NIA R01-equivalent.

6 Reviewer-Risk Notes For Aging Leadership Teams

Within 21 days, write 6 reviewer-risk notes before drafting the career plan. Note 1 is leadership ownership. A common mistake is treating academic leadership as a title. Reviewers need to see what changes: a new training pathway, a shared method resource, a mentoring system, a data resource, a recruitment plan, or a department-level aging-research capacity gap that this candidate can fix.

Note 2 is aging mission fit. A general health-services leader may look close to NIA, but the application can still be weak if aging is only a population label. The route is stronger when aging biology, AD/ADRD, geroscience, cognition, caregiving, mobility, long-term care, disparities in aging, or another NIA-aligned question owns the plan.

Note 3 is the institutional letter. The pitfall is a letter that praises the candidate but does not transfer authority, time, staff, space, data access, or long-term support. A 2-column letter draft helps: what the institution gives during the award and what it commits after the award.

Note 4 is the no-trial boundary. According to NIH PAR-24-321, the candidate cannot lead an independent clinical trial. If the plan includes a trial, write who leads it, what the K07 candidate does, and why the career plan still fits this no-trial route. Don't leave that to reviewer inference.

Note 5 is the route comparison. K07 should beat K01, K24, K12, R01, and R03 for a reason. If the best answer is K24 or R01, say that early.

Note 6 is eligibility proof. According to PAR-24-321, the candidate must be a named PD/PI on an active NIA R01, R01-equivalent, or sub-project of a multi-component NIA award at submission, and must document efforts to replace that support if it ends during the award. Name the grant number in the candidate section so reviewers don't have to look for it.

5 Before-Drafting Questions

Within 10 minutes, answer these 5 questions before drafting. First, what aging-research leadership capacity changes if funded? Second, who at the institution has authority to protect the candidate's role? Third, what does the candidate learn or build that is not already available? Fourth, how is the no-trial status handled? Fifth, why is K07 better than K01, K24, K12, R01, or R03?

If the answers are vague, revise before drafting. If the route might fit but the evidence is uneven, fix the weakest item first: leadership role, aging mission, institutional backing, trial boundary, or route alternatives.

One extra check is worth doing before the team opens ASSIST: ask the chair to rewrite the leadership promise in operational terms. A useful letter says the candidate will direct a named seminar, build a data resource, mentor 3 junior investigators, run a methods group, or lead an aging-research process with dates and owners. A weak letter says the institution is excited. That difference changes reviewer confidence.

5 FAQ Answers

Is PAR-24-321 a clinical-trial route?

No. According to NIH PAR-24-321, the candidate cannot lead an independent clinical trial under this route.

Is K07 the same as K01?

No. K01 is usually a mentored career-development route. K07 is a leadership and academic career route, so the application needs a different story.

Can an institution use K07 as general faculty support?

No. The plan needs aging-research leadership value, not generic salary support.

What should I check before drafting?

Check PAR-24-321 (including the active NIA R01-equivalent requirement), the live NIA Academic Leadership K07 program record, the career plan, and the institutional letter.

What should I prepare first?

Prepare a 1-page route memo, candidate CV, career plan outline, institutional-support draft, trial-role memo, and aging mission paragraph.

Sources

• NIH PAR-24-321
• NIH K07 activity code
• NIA training and career development
• Grants.gov
• NIA Academic Leadership K07 program record